HESG Health Sciences Group Inc (CE)

Health Sciences Group (OTC Pink: HESG) today announced that management has taken necessary steps this week to file OTC Full Disclosure documents and financials to update to highest tier status on OTCMarkets. Also, Company has committed to provide regular disclosures and transparency to investors. Regular public disclosure and financial reporting enhances the Company's credibility among both industry peers and public investors.

Tier status upgrade will be granted as soon as OTCMarkets Group has reviewed and approved all filings. Investors can access the Company's public filings at www.otcmarkets.com.

The Company expects to make further announcements regarding its current joint venture/co-development efforts with OTC-listed InternetArray to develop state-of-the-art medical marijuana mobile apps. Concurrently, management has identified several key strategic partners and negotiation is underway to bring in complimentary cannabis products and services to further expand our global markets reach.

"We're comfortable that our filings will be approved and granted CURRENT tier status within the next few days. During the last few weeks, management has negotiated with potential business partners both in the US and overseas to identify strategic fit for our business model. This time we feel that we're ready to execute our planned strategies and will update our investors with upcoming breakthroughs and technologies," stated Mr. Nhue "Nick" Le, Chief Executive Officer.

About Health Sciences Group, Inc.

Health Sciences Group, Inc. is an investment technology portfolio company that acquires nascent health sciences technology and related innovations, inventions and IP assets to enhance their growth and development. The company builds revenues and asset value through a model of continuous growth, income from or sale of its portfolio holdings, and technology licensing or distribution agreements.

This release contains forward-looking statements within the meaning of Section 27a of the Securities Act of 1933, as amended and Section 21e of the Securities and Exchange Act of 1934, as amended. Those statements include the intent, belief or current expectations of the company and its management team. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Accomplishing the strategy described herein is significantly dependent upon numerous factors, many that are not in management's control. Some of these factors include the ability of the company to raise sufficient capital, attract qualified management, attract new customers and effectively compete against similar companies.

Contact: Investor Relations (800) 549-3067 info@hesciencesgroup.com